General Information
Version
6.3
Revision date
2023-09-21
Product name
PCS1055
CAS No.
357173-55-8
Emergency telephone
+44 (0)870 8200418
Icons in SDS
Company Information
company name
Merck Life Science UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
none
Hazard Codes
Hazard statements (CLP)
H413
Hazard statements
Code
Statements
H413
May cause long lasting harmful effects to aquatic life
Section 2
SECTION 2: Hazards identification
Labelling according Regulation (EC) No 1272/2008 as amended by GB-CLP Classification of the substance or mixture
Hazard pictograms
none none
Signal word
none none
Hazard statements
H413 May cause long lasting harmful effects to aquatic life. Reduced Labeling (<= 125 ml) H413 May cause long lasting harmful effects to aquatic life.
Precautionary statements
P273 Avoid release to the environment. P501 Dispose of contents/ container to an approved waste disposal plant. none
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 as amended by GB-CLP Regulation, UK SI 2019/720, and UK SI 2020/1567 Long-term (chronic) aquatic hazard (Category 4), H413 For the full text of the H-Statements mentioned in this Section, see Section 16.